These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38811860)

  • 1. Clinical impact of fluoropolymer-based drug-eluting stent thrombosis in femoropopliteal artery occlusive lesions.
    Shimizu H; Kobayashi T; Okazaki T; Mochizuki S; Maeda K; Sato T; Emura S; Arai Y; Kato Y; Takahashi S
    Vascular; 2024 May; ():17085381241258553. PubMed ID: 38811860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
    AbuRahma AF; Beasley M; AbuRahma ZT; Davis M; Adams E; Dean LS; Shapiro J; Scott G; Davis E
    J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical Trial Comparing drug Eluting Stent Zilver PTX® Versus Bare Metal Stent Zilver Flex® for Treatment of Lesions in Femoral and Popliteal Arteries in Chronic Limb Threatening Ischemia.
    Fransson T; Gottsäter A; Abdulrasak M; Malina M; Resch T
    Vasc Endovascular Surg; 2023 Oct; 57(7):706-716. PubMed ID: 37085152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year clinical course after fluoropolymer-based drug-eluting stent implantation for femoropopliteal lesions.
    Iida O; Takahara M; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Sakata Y; Mano T; Higuchi Y
    Vasc Med; 2024 Apr; 29(2):182-188. PubMed ID: 38457137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-Analysis of Efficacy and Safety of Cilostazol Prescription in Patients With Femoropopliteal Peripheral Artery Disease After Endovascular Therapy.
    Tan Q; Chen Z; Wu H; Wang H; Chen J; Lai K; Zhang F; Kang T; Zheng J
    J Endovasc Ther; 2024 Apr; ():15266028241241248. PubMed ID: 38590247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2016 Apr; 9(8):828-834. PubMed ID: 27101908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after Endovascular Stent Placement for Long-Segment Superficial Femoral Artery Lesions.
    Zamani N; Sharath SE; Browder RC; Barshes NR; Braun JD; Mills JL; Kougias P; Younes HK
    Ann Vasc Surg; 2021 Feb; 71():298-307. PubMed ID: 32891746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration.
    Iida O; Takahara M; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Nanto S; Sakata Y; Mano T;
    JACC Cardiovasc Interv; 2022 Mar; 15(6):630-638. PubMed ID: 35331454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Yokoi H; Uematsu M;
    J Vasc Surg; 2016 Dec; 64(6):1691-1695.e1. PubMed ID: 27575807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis.
    Hayakawa N; Kodera S; Takanashi K; Kanagami T; Ichihara S; Arakawa M; Hirano S; Inoguchi Y; Shakya S; Kanda J
    Cardiovasc Revasc Med; 2022 Oct; 43():87-96. PubMed ID: 35469761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.
    Liistro F; Angioli P; Porto I; Ducci K; Falsini G; Ventoruzzo G; Ricci L; Scatena A; Grotti S; Bolognese L
    J Am Coll Cardiol; 2019 Jul; 74(2):205-215. PubMed ID: 31296293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia.
    Kum S; Ipema J; Huizing E; Tan YK; Lim D; Lok IY; Hazenberg CE; Ünlü Ç
    Vasc Med; 2021 Jun; 26(3):267-272. PubMed ID: 33733963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
    Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
    J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
    [No Abstract]   [Full Text] [Related]  

  • 16. 1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty.
    Bisdas T; Beropoulis E; Argyriou A; Torsello G; Stavroulakis K
    JACC Cardiovasc Interv; 2018 May; 11(10):957-966. PubMed ID: 29798772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions.
    Tsujimura T; Iida O; Takahara M; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Nanto S; Sakata Y; Mano T;
    JACC Cardiovasc Interv; 2022 Aug; 15(15):1569-1578. PubMed ID: 35926923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Registry of Common Femoral Artery Disease Treated With Endovascular Revascularization Using Interwoven Nitinol Stents: An Observational Retrospective Study.
    Horie K; Takahara M; Nakama T; Tobita K; Tanaka A; Shintani Y; Tsubakimoto Y; Yoshioka N; Hayakawa N; Sasaki S; Iwata Y; Ogata K; Takagi T; Doijiri T; Fujihara M
    J Endovasc Ther; 2024 Feb; ():15266028241231472. PubMed ID: 38369732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Acute Thrombotic Occlusion and Its Predictors After Contemporary Femoropopliteal Endovascular Therapy in Patients With Peripheral Artery Disease.
    Nakao S; Iida O; Takahara M; Okamoto S; Ishihara T; Tsujimura T; Hata Y; Toyoshima T; Higashino N; Mano T
    J Endovasc Ther; 2024 Apr; 31(2):263-273. PubMed ID: 36052430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan.
    Mori S; Hirano K; Yamauchi Y; Hayashi E; Doijiri T; Takamura T; Maeda A; Okuda J; Mizuno K; Onishi Y; Iwaki T; Tsukahara K; Shinozaki N; Araki H; Kongoji K; Sugano T; Miyamoto A; Michishita I
    Heart Vessels; 2017 Sep; 32(9):1093-1098. PubMed ID: 28451834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.